{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:43:42Z","timestamp":1791546222056,"version":"4.3.4"},"reference-count":10,"publisher":"American Association for Cancer Research (AACR)","issue":"21","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11,2]]},"abstract":"<jats:p>Immunotherapy of cancer is a burgeoning field of research since the realization that our immune system intrinsically has the capacity to restrict tumor occurrence and progression. Though strategies to maximize antitumor T-cell activation are well established, the efficacy of these therapies is limited by an insufficient knowledge of the intricate tumor microenvironment and its capacity to thwart antitumor immunity. Chen and colleagues now uncover a novel immunosuppressive pathway in non\u2013small cell lung carcinoma. Overexpression of cytochrome P450F2 in cancer cells increases production of 20-hydroxyeicosatetraenoic acid, which instructs the expression of immunosuppressive molecules in cancer-associated fibroblasts by binding the GPR75 receptor and activating STAT3\/c-Jun signaling. This work proposes several innovative therapeutic anchor points that may improve the efficacy of existing immunotherapies.<\/jats:p>\n               <jats:p>See related article by Chen et al., p. 4016<\/jats:p>","DOI":"10.1158\/0008-5472.can-22-2774","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T07:17:09Z","timestamp":1667373429000},"page":"3882-3883","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Heat Is On: 20-HETE Instructs an Immunosuppressive Phenotype in Cancer-Associated Fibroblasts"],"prefix":"10.1158","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4442-7474","authenticated-orcid":false,"given":"Jo A.","family":"Van Ginderachter","sequence":"first","affiliation":[{"name":"1Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium."},{"name":"2Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"2022110217350465200_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41573-021-00345-8","article-title":"The foundations of immune checkpoint blockade and the ipilimumab approval decennial","volume":"21","author":"Korman","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"2022110217350465200_bib2","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat Immunol"},{"key":"2022110217350465200_bib3","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/eji.202149358","article-title":"Regulatory T-cell development in the tumor microenvironment","volume":"52","author":"Itahashi","year":"2022","journal-title":"Eur J Immunol"},{"key":"2022110217350465200_bib4","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/0008-5472.CAN-21-4029","article-title":"CYP4F2-catalyzed metabolism of arachidonic acid promotes stromal cell\u2013mediated immunosuppression in non\u2013small cell lung cancer","volume":"82","author":"Chen","year":"2022","journal-title":"Cancer Res"},{"key":"2022110217350465200_bib5","doi-asserted-by":"crossref","first-page":"580897","DOI":"10.3389\/fphar.2020.580897","article-title":"Pleiotropic functions of cytochrome P450 monooxygenase-derived eicosanoids in cancer","volume":"11","author":"Luo","year":"2020","journal-title":"Front Pharmacol"},{"key":"2022110217350465200_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"2022110217350465200_bib7","doi-asserted-by":"crossref","first-page":"595498","DOI":"10.3389\/fphar.2020.595498","article-title":"Eicosanoids in cancer: new roles in immunoregulation","volume":"11","author":"Johnson","year":"2020","journal-title":"Front Pharmacol"},{"key":"2022110217350465200_bib8","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"2022110217350465200_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"2022110217350465200_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41568-021-00413-6","article-title":"Overcoming TGF\u03b2-mediated immune evasion in cancer","volume":"22","author":"Tauriello","year":"2022","journal-title":"Nat Rev Cancer"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/82\/21\/3882\/3217547\/3882.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/82\/21\/3882\/3217547\/3882.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T17:35:40Z","timestamp":1667410540000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/82\/21\/3882\/709948\/The-Heat-Is-On-20-HETE-Instructs-an"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":10,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11,2]]},"published-print":{"date-parts":[[2022,11,2]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-22-2774","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]}}}